Leading Ophthalmic Photocoagulator Application Markets Databank
The Ophthalmic Photocoagulator market was valued at $150.2 Million in 2020, and is projected to reach $251.5 Million by 2029 growing at a CAGR of 5.94% from 2021 to 2029. Diabetic Retinopathy segment is expected to be the highest contributor to this market, with $51.0 Million in 2020, and is anticipated to reach $85.0 Million by 2029, registering a CAGR of 5.89%. Age-related Macular Degeneration segment is anticipated to reach $47.7 Million by 2029 with the highest CAGR of 6.04%. Diabetic Retinopathy and Glaucoma segments collectively expected to account for about 56.3% share of the Ophthalmic Photocoagulator market in 2020, with the former constituting around 33.9% share. Age-related Macular Degeneration and Macular Edema segments are expected to witness significant growth rates at a CAGR of 6.04% and 6.01% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 30.4% in the overall Ophthalmic Photocoagulator market in 2020, and is anticipated to reach 30.6% by 2029.
- 1. GLOBAL OPHTHALMIC PHOTOCOAGULATOR MARKET, BY APPLICATION
- 1.1. OVERVIEW
- 1.2. GLAUCOMA
- 1.2.1 GLAUCOMA MARKET, BY REGION
- 1.2.1.1 North America Glaucoma Market, By Country
- 1.2.1.2 Europe Glaucoma Market, By Country
- 1.2.1.3 Asia-Pacific Glaucoma Market, By Country
- 1.2.1.4 Rest of World Glaucoma Market, By Country
- 1.3. DIABETIC RETINOPATHY
- 1.3.1 DIABETIC RETINOPATHY MARKET, BY REGION
- 1.3.1.1 North America Diabetic Retinopathy Market, By Country
- 1.3.1.2 Europe Diabetic Retinopathy Market, By Country
- 1.3.1.3 Asia-Pacific Diabetic Retinopathy Market, By Country
- 1.3.1.4 Rest of World Diabetic Retinopathy Market, By Country
- 1.4. AGE-RELATED MACULAR DEGENERATION
- 1.4.1 AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION
- 1.4.1.1 North America Age-related Macular Degeneration Market, By Country
- 1.4.1.2 Europe Age-related Macular Degeneration Market, By Country
- 1.4.1.3 Asia-Pacific Age-related Macular Degeneration Market, By Country
- 1.4.1.4 Rest of World Age-related Macular Degeneration Market, By Country
- 1.5. MACULAR EDEMA
- 1.5.1 MACULAR EDEMA MARKET, BY REGION
- 1.5.1.1 North America Macular Edema Market, By Country
- 1.5.1.2 Europe Macular Edema Market, By Country
- 1.5.1.3 Asia-Pacific Macular Edema Market, By Country
- 1.5.1.4 Rest of World Macular Edema Market, By Country
- 1.6. OTHER APPLICATIONS
- 1.6.1 OTHER APPLICATIONS MARKET, BY REGION
- 1.6.1.1 North America Other Applications Market, By Country
- 1.6.1.2 Europe Other Applications Market, By Country
- 1.6.1.3 Asia-Pacific Other Applications Market, By Country
- 1.6.1.4 Rest of World Other Applications Market, By Country
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook